Targeted modulation of macrophages
OwnerTheophilus Thepen, Dmitrij Hristodorov +2inventors
InventorsTheophilus Thepen, Dmitrij Hristodorov, Radoslav Mladenov, Stefan Barth
Life of this patent
Estimating the term…
Loading patent…
OwnerTheophilus Thepen, Dmitrij Hristodorov +2inventors
InventorsTheophilus Thepen, Dmitrij Hristodorov, Radoslav Mladenov, Stefan Barth
Estimating the term…
An immunomodulatory fusion protein (IFP) for converting pro-inflammatory M macrophages to anti-inflammatory M2 like phenotypes of macrophagesthe IFP having at least one component A and at least one component B wherein the component A is comprising or consisting of a binding domain for extra-cellular surface structures of a macrophage that internalizes said immunomodulatory fusion protein upon binding of component A of said immunomodulatory fusion protein, and the component B is modulating the macrophage and comprises or consists of a DNA oligonucleotide or RNA oligonucleotide or a chemical small molecule exhibiting modulatory functions to targeted macrophages or a polypeptide which amino acid sequence comprises or consists of a macrophage modulatory protein or comprises or consists of at least a partial sequence of the macrophage modulatory protein, the partial sequence having maintained the modulatory function of the macrophage modulatory protein.
An immunomodulatory fusion protein (IFP) for converting pro-inflammatory M1 macrophages to anti-inflammatory M2 like phenotypes of macrophages,. the IFP having at least one component A and at least one component, wherein
Dependencies are inferred from the claim text.